Restoration of transforming growth factor β signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1- mediated apoptosis

Cancer Research

Volumn 59, Issue 6, 1999, Pages 1366-1371

  Guo, Yanping ^a   Kyprianou, Natasha ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; CANCER CELL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CASPASE 1; CELL TRANSFORMATION, NEOPLASTIC; DNA FRAGMENTATION; ENZYME INDUCTION; HUMANS; MALE; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0033559189     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Isaacs, J. T. Antagonistic effect of androgens on prostate cell death. Prostate, 5: 545-558, 1984.
2. Kyprianou, N., and Isaacs, J. T. Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology. 122: 552-562, 1988.
3. Martikainen, P., Kyprianou, N., and Isaacs, J. T. Effect of transforming growth factor-β1 on proliferation and death of rat prostatic cells. Endocrinology, 127: 2963-2968, 1990.
4. Thompson, T. C. A review: growth factors and oncogenes in prostate cancer. Cancer Cells, 2: 345-354, 1990.
5. Kyprianou, N. Role of apoptosis in development of benign prostatic hyperplasia (BPH) and prostate cancer: prostate cancer: clinical significance in diagnosis and treatment. In: R. K. Naz (ed.), Prostate: Basic and Clinical Aspects, pp. 181-193. New York: CRC Press, 1997.
6. Steiner, M. S. Peptide growth factors in prostate cancer. In: R. K. Naz (ed.), Prostate: Basic and Clinical Aspects, pp. 151-179. New York: CRC Press, 1997.
7. Kyprianou, N., and Isaacs, J. T. Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death. Mol. Endocrinol., 3: 1515-1522, 1989.
8. Kyprianou, N., and Isaacs, J. T. Identification of a cellular receptor for TGF-β in the rat ventral prostate and its negative regulation on androgens. Endocrinology, 123: 2124-2131, 1988.
9. Hsing, A. Y., Kadomatsu, K., Bonham, M. J., and Danielpour, D. Regulation of apoptosis induced by transforming growth factor-β1 in nontumorigenic and tumorigenic rat prostatic epithelial cell lines. Cancer Res., 56: 5146-5149, 1996.
10. Tu, H., Jacobs, S. C., Borkowski, A., and Kyprianou, N. Significance of apoptosis in prostate cancer progression: relationship with cell proliferation, TGF-β1 and bcl-2 expression. Int. J. Cancer, 69: 357-363, 1996.
11. Lin, H. Y., Wang, X., Ng-Eaton, E., Weinberg, R. A., and Lodish, H. F. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell, 68: 775-785, 1992.
12. Wieser, R., Attisano, L., Wrana, J. F., and Massague, J. Signaling activity of transforming growth factor type II receptors lacking specific domains in the cytoplasmic region. Mol. Cell. Biol., 13: 7239-7247, 1993.
13. Wrana, J., Attisano, L., Carcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X. F., and Massague, J. TGF-β signals through a heteromeric protein kinase receptor complex. Cell, 71: 1003-1014, 1992.
14. Wrana, J., Attisano, L., Wiesert, R., Ventura, F., and Massague, J. Mechanism of activation of the TGF-β receptor. Nature (Lond.), 370: 341-347, 1994.
15. Sun, L., Wu, G., Wilson, J. K., Zborowska, E., Yang, J., Rajkarunanyake, J., Wang, J., Gentry, L. E., Wang, X-F., and Brattain, M. G. Expression of transforming growth factor-β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J. Biol. Chem., 269: 26449-26455, 1994.
16. Kadin, M. E., Cavill-Coll, M. N., Gertz, R., Massague, J., Cheifez, S., and George, D. Loss of receptors for transforming growth factor-β in human T-cell malignancies. Proc. Natl. Acad. Sci. USA, 91: 6002-6006, 1994.
17. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L-Z., Lutterbaugh, J., Zborowska, E., Kinzler, K. W. Vogelstein, B., Brattain, M., and Willson, J. K. V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 68: 1336-1338, 1995.
18. Garrigue-Antar, L., Muñoz-Antonia, T., Antonia, S. J., Gesmonde, J., Vellucci, V. F., and Reiss, M. Missense mutations of the transforming growth factor-β type II receptor in human head and neck squamous carcinoma cells. Cancer Res., 55: 3982-3987, 1995.
19. Guo, Y., Jacobs, S. C., and Kyprianou, N. Down-regulation of mRNA and protein expression for TGF-β type I and type II receptors in human prostate cancer. Int. J. Cancer, 71: 573-579, 1997.
20. Kim, I. Y., Ahn, H-J., Zelner, D. J., Shaw, J. W., Lang, S., Kato, M., Oefelein, M. G., Miyazono, K., Nemeth, J. A., Kozlowski, J. M., and Lee, C. Loss of expression of transforming growth factor β type I and type II receptors correlates with tumor grade in human prostate cancer tissues. Clin. Cancer Res., 2: 1255-1261, 1996.
21. Guo, Y., and Kyprianou, N. Overexpression of transforming growth factor (TGF) β1 type II receptor restores TGF-β1 sensitivity and signaling in human prostate cancer cells. Cell Growth Diff., 9: 185-193, 1998.
22. Williams, R. H., Stapleton, A. M. F., Yang, G., Truong, L. D., Rogers, E., Timme, T. L., Wheeler, T. M., Scardino, P. T., and Thompson, T. C. Reduced levels of TGF-β receptor type II in human prostate cancer: an immunohistochemical study. Clin. Cancer Res., 2: 635-, 1996.
23. Selvakumaran, M., Lin, H-K., Sjin, R. T., Reed, J. C., Lieberman, D. A., and Hoffman, B. The novel primary response gene Myd118 and the protooncogenes myb, myc and bcl-2 modulate transforming growth factor β1-induced apoptosis of myeloid leukemia cells. Mol. Cell. Biol., 14: 2352-2360, 1994.
24. Rotello, R. J., Liebermann, R. C., Purchio, A. F., and Gerschenson, L. E. Coordinated regulation of apoptosis and cell proliferation by transforming growth factor-β1 in cultured uterine epithelial cells. Proc. Natl. Acad. Sci. USA. 88: 3412-3415, 1991.
25. Yanagihara, K., and Tsumuraya, M. Transforming growth factor-β1 induces apoptotic cell death in cultured human gastric carcinoma cells. Cancer Res., 52: 4042-4045, 1992.
26. Wang, C. Y., Eshleman, J. R., Willson, J. K. V., and Markowitz, S. Both transforming growth factor-β and substrate release are inducers of apoptosis in a human colon adenoma cell line. Cancer Res., 55: 5101-5105, 1995.
27. Oberhammer, F. A., Pavelka, M., Sharma, S., Tiefenbacher, R., Purchio, A. F., Bursch, W., and Schulte-Hermann, R. Induction of apoptosis in cultured hepatocyte and in regressing liver by transforming growth factor-β1. Proc. Natl. Acad. Sci. USA, 89: 5408-5412, 1992.
28. Fukuda, K., Kojiro, M., and Chiu, J-F. Induction of apoptosis by transforming growth factor-β1 in the rat hepatoma cell line McA-RH7777: a possible association with tissue transglutaminase expression. Hepatology, 18: 945-952, 1993.
29. Reed, J. C. Bcl-2 and the regulation of programmed cell death. J. Cell. Biol., 124: 1-12, 1994.
30. Kroemer, G. The protooncogene bcl-2 and its role in regulating apoptosis. Nat. Med., 3: 614-620, 1997.
31. xL and Bcl-2, displaces Bax and promotes cell death. Cell, 80: 285-291, 1995.
32. Sedlak, T. W., Oltvi, Z. N., Yang, E., Wang, K., Boise, L. H., and Korsmeyer, S. J. Multiple bcl-2 family members demonstrate selective dimerizations with bax. Proc. Natl. Acad. Sci. USA, 92: 7834-7838, 1995.
33. Herrmann, J. L., Menter D. G., Beham A., Eschenbach A., and McDonnell, T. J. Regulation of lipid signaling pathways for cell survival and apoptosis by bcl-2 in prostate carcinoma cells. Exp. Cell Res., 234: 442-451, 1997.
34. Raffo, A. J., Perlman, H., Chen. M-W., Day, M. L., Streitman, J. S., and Buttyan, R. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res., 55: 4438-4445, 1995.
35. Kyprianou, N., King, E. D., Bradbury, D., Rhee, J. G., Bcl-2 overexpression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells. Int. J. Cancer, 70: 341-348, 1997.
36. Alnermri, E. S., Livingston, D. J., Nicholson, D. W., Salvesen, G., Thornberry, N. A., Wong. W. W., and Yuan, J. Y. Human ICE/CED-3 protease nomenclature. Cell, 87: 171, 1996.
37. Whyte, M. ICE/CED-3 proteases in apoptosis. Trends Cell Biol., 6: 245-248, 1996.
38. Troy, C. M., Stafanis, L., Prochiantz, A., Greene. E. A., and Shelanski, M. E., The contrasting roles of ICE family proteases and interleukin-Iβ in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulalion. Proc. Natl. Acad. Sci. USA. 93: 5635-5640, 1996.
39. Enari, M., Hug, H., and Nagata, S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature (Lond.), 375: 78-81, 1995.
40. Choi, K. S. Lim, I. K., Brady, J. N., and Kim S. J. ICE-like protease (caspase) is involved in transforming growth factor β1-mediated apoptosis in FaO rat hepatoma cell line. Hepatology, 27: 415-421, 1998.
41. Chen, R. H., and Chang, T. Y. Involvement of caspase family proteases in transforming growth factor-β-induced apoptosis. Cell Growth Differ., 8: 821-827, 1997.
42. Gavriey, Y., Sherman, Y., and Bensasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentatioin. J. Cell Biol., 119: 493-501, 1992.
43. 2+-dependent endonuclease as an early event in castration-induced prostatic cell death. Prostate, 13: 103-118, 1988.
44. Kostura, M. J., Tocci, M. J., Limjuco, G., Chin, J., Cameron, P., Hillman A. G., Chartain, N. A., and Schmidt, J. A. Idenlification of a monocyte specific preinterleukin 1β convertase activity. Proc. Natl. Acad. Sci. USA, 86: 5227-5231, 1989.
45. Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., and Tocci, M. J. A novel heterodimeric protease is required for interleukin-1β processing in monocytes. Nature (Lond.), 356: 768-774, 1992.